Our research pioneers the validation of ACRR2B-AS1 and MANEA-DT as independent prognostic factors for ccRCC through RT-qPCR experiments at the mRNA level using cell lines, complemented with data from external databases. This evidence concerns the gene MANEA and nonpapillary renal cell carcinoma.